v3.22.2.2
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities    
Net loss $ (8,521,876) $ (3,783,388)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation 0 591
Change in fair value of warrant liabilities (1,591,055) 1,084,052
Noncash interest expense 0 961,680
Issuance of stock in exchange for services 39,929 0
Stock-based compensation expense 106,713 0
Changes in operating assets and liabilities:    
Deferred cost 0 (2,330,738)
Prepaid expenses and other current assets (1,714,241) 0
Accounts payable (498,463) 775,101
Accrued interest 0 0
Accrued expenses and other current liabilities 1,510,531 (773,922)
Net cash used in operating activities (10,668,462) (4,066,624)
Cash flows from financing activities    
Issuance of common stock in lieu of deferred compensation 0 340,932
Proceeds from business combination, net of costs 0 9,375,961
Proceeds from issuance of Units in public offering, net 31,497,463 0
Proceeds from issuance of stock upon warrant exercises 98,481 0
Proceeds from issuance of convertible promissory notes 0 3,110,000
Net cash provided by financing activities 31,595,944 12,826,893
Net increase (decrease) in cash 20,927,482 8,760,269
Cash, beginning of period 8,760,462 193
Cash, end of period 29,687,944 8,760,462
Supplemental disclosures of cash flow information:    
Cash paid for taxes 2,400 800
Cash paid for interest 0 327,076
Supplemental schedule of noncash financing and investing activities:    
Conversion of convertible promissory notes into common stock 0 6,875,088
Payment of certain deferred costs from proceeds from business combination $ 0 $ 1,000,000